Briefing
MolDX lists three named assays for recurrence testing in advanced colorectal cancer
The MolDX billing article A58434, in the revision effective January 1, 2026, lists Signatera, Guardant Reveal, and Oncodetect for the diagnosis of progression, recurrence, or relapse in advanced colorectal cancer.